Hikma Pharmaceuticals Balance Sheet
Hikma Pharmaceuticals's total assets for Q4 2025 were $5.67B, an increase of 2.14% from the previous quarter. DE:H5P total liabilities were $3.07B for the fiscal quarter, a 2.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.